Moderna Awarded $590 Million for Bird Flu Vaccine Development
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads significantly. With only a 5% chance of a bird flu pandemic ...
The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback